PNC Financial Services Group
TNGX icon

PNC Financial Services Group’s Tango Therapeutics TNGX Stock Holding History

PNC Financial Services Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.63K Hold
212
– – ﹤0.01% 4286
2026
Q1 		$4.44K Hold
212
– – ﹤0.01% 4317
2025
Q4 		$1.88K Hold
212
– – ﹤0.01% 4539
2025
Q3 		$1.78K Hold
212
– – ﹤0.01% 4534
2025
Q2 		$1.09K Sell
212
-45
-18% -$111 ﹤0.01% 4551
2025
Q1 		$352 Sell
257
-562
-69% -$1.38K ﹤0.01% 4702
2024
Q4 		$2.53K Hold
819
– – ﹤0.01% 4221
2024
Q3 		$6.31K Hold
819
– – ﹤0.01% 3971
2024
Q2 		$7.03K Buy
+819
New +$6.33K ﹤0.01% 3897

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

PNC Financial Services Group's TNGX Position: Q2 2026 in Review

PNC Financial Services Group held its Tango Therapeutics (TNGX) position steady in Q2 2026 at 212 shares worth $6.63K. The position accounts for ﹤0.01% of the portfolio, ranked #4286.

PNC Financial Services Group first reported a position in TNGX in Q2 2024 and has held it in 9 quarters since. The position peaked at $7.03K in Q2 2024. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • PNC Financial Services Group held 212 shares of Tango Therapeutics worth $6.63K as of Q2 2026.
  • PNC Financial Services Group left its Tango Therapeutics share count unchanged in Q2 2026.
  • Tango Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4286 holding.
  • PNC Financial Services Group first reported a position in Tango Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • PNC Financial Services Group's Tango Therapeutics position peaked at $7.03K in Q2 2024.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.